Finally, very recently in a small study, the 11β-hydroxysteroid dehydrogenase (11BHSD) type 1 (11BHSD1) inhibitor S-707106 demonstrated an effective insulin sensitizer, anti-sarcopenic and anti-obesity effect in both CS and mHC patients [41]. Here, INS is linked to Obesity.